Larry Brooks

848 total citations
17 papers, 672 citations indexed

About

Larry Brooks is a scholar working on Pharmacology, Psychiatry and Mental health and Social Psychology. According to data from OpenAlex, Larry Brooks has authored 17 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Psychiatry and Mental health and 4 papers in Social Psychology. Recurrent topics in Larry Brooks's work include Musculoskeletal pain and rehabilitation (7 papers), Stress Responses and Cortisol (3 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). Larry Brooks is often cited by papers focused on Musculoskeletal pain and rehabilitation (7 papers), Stress Responses and Cortisol (3 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). Larry Brooks collaborates with scholars based in United States and Australia. Larry Brooks's co-authors include David Loewenstein, Angela Szeto, Armando J. Mendez, Philip M. McCabe, Daniel A. Nation, Neil Schneiderman, Carlos J. Lavernia, Juan Domínguez‐Bendala, Mark D. Rossi and Jose C. Alcerro and has published in prestigious journals such as American Journal of Physiology-Endocrinology and Metabolism, Psychosomatic Medicine and Archives of Physical Medicine and Rehabilitation.

In The Last Decade

Larry Brooks

17 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry Brooks United States 12 195 135 134 111 98 17 672
Jan Martin Germany 16 308 1.6× 108 0.8× 60 0.4× 78 0.7× 120 1.2× 38 807
Rob van Diest Netherlands 18 79 0.4× 43 0.3× 71 0.5× 59 0.5× 61 0.6× 28 1.0k
Huynh Giao Ly Belgium 18 80 0.4× 201 1.5× 155 1.2× 247 2.2× 49 0.5× 30 955
Cody Ashe-McNalley United States 17 123 0.6× 79 0.6× 162 1.2× 323 2.9× 20 0.2× 27 1.0k
Jenny Nyberg Sweden 15 63 0.3× 91 0.7× 109 0.8× 202 1.8× 43 0.4× 32 857
Jui‐Yang Hong United States 13 126 0.6× 64 0.5× 145 1.1× 289 2.6× 15 0.2× 20 847
Janean E. Holden United States 18 65 0.3× 60 0.4× 72 0.5× 437 3.9× 107 1.1× 41 941
Tammie Quinn United States 16 44 0.2× 32 0.2× 124 0.9× 242 2.2× 48 0.5× 40 638
Steven J. Coen United Kingdom 15 108 0.6× 122 0.9× 154 1.1× 303 2.7× 35 0.4× 34 1.0k
María del Carmen García Ríos Spain 12 63 0.3× 67 0.5× 109 0.8× 54 0.5× 14 0.1× 39 587

Countries citing papers authored by Larry Brooks

Since Specialization
Citations

This map shows the geographic impact of Larry Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Brooks more than expected).

Fields of papers citing papers by Larry Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Brooks. The network helps show where Larry Brooks may publish in the future.

Co-authorship network of co-authors of Larry Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Larry Brooks. A scholar is included among the top collaborators of Larry Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry Brooks. Larry Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wilkerson, Gary B., et al.. (2025). Perceptual Decision Efficiency Is Modifiable and Associated with Decreased Musculoskeletal Injury Risk Among Female College Soccer Players. Brain Sciences. 15(7). 721–721. 1 indexed citations
2.
Richardson, Elizabeth J., Larry Brooks, J. S. Richards, et al.. (2016). Changes in pain and quality of life in depressed individuals with spinal cord injury: does type of pain matter?. Journal of Spinal Cord Medicine. 39(5). 535–543. 10 indexed citations
3.
Fann, Jesse R., Charles H. Bombardier, J. S. Richards, et al.. (2015). Venlafaxine Extended-Release for Depression Following Spinal Cord Injury. JAMA Psychiatry. 72(3). 247–247. 36 indexed citations
4.
Lavernia, Carlos J., et al.. (2015). The Cost–Utility of Total Hip Arthroplasty: Earlier Intervention, Improved Economics. The Journal of Arthroplasty. 30(6). 945–949. 36 indexed citations
6.
Bryce, Thomas N., J. S. Richards, Charles H. Bombardier, et al.. (2014). Screening for neuropathic pain after spinal cord injury with the Spinal Cord Injury Pain Instrument (SCIPI): a preliminary validation study. Spinal Cord. 52(5). 407–412. 36 indexed citations
7.
Richards, J. Scott, Charles H. Bombardier, Catherine S. Wilson, et al.. (2014). Efficacy of Venlafaxine XR for the Treatment of Pain in Patients With Spinal Cord Injury and Major Depression: A Randomized, Controlled Trial. Archives of Physical Medicine and Rehabilitation. 96(4). 680–689. 37 indexed citations
8.
Amber, Kyle T., et al.. (2014). Assessing the Perceptions of Fibromyalgia Syndrome in United States Among Academic Physicians and Medical Students: Where are We and Where are We Headed?. Journal of Musculoskeletal Pain. 22(1). 13–19. 10 indexed citations
9.
Bombardier, Charles H., Jesse R. Fann, Catherine S. Wilson, et al.. (2013). A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned. Journal of Spinal Cord Medicine. 37(3). 247–263. 12 indexed citations
10.
Brooks, Larry, et al.. (2012). The Relationship Between Performances on Neuropsychological Symptom Validity Testing and the MCMI-III in Patients With Fibromyalgia. The Clinical Neuropsychologist. 26(5). 816–831. 10 indexed citations
11.
Lavernia, Carlos J., Jose C. Alcerro, Larry Brooks, & Mark D. Rossi. (2012). Mental Health and Outcomes in Primary Total Joint Arthroplasty. The Journal of Arthroplasty. 27(7). 1276–1282. 86 indexed citations
12.
Loewenstein, David, Maria T. Greig, John A. Schinka, et al.. (2012). An investigation of PreMCI: Subtypes and longitudinal outcomes. Alzheimer s & Dementia. 8(3). 172–179. 37 indexed citations
13.
Nation, Daniel A., Angela Szeto, Armando J. Mendez, et al.. (2010). Oxytocin Attenuates Atherosclerosis and Adipose Tissue Inflammation in Socially Isolated ApoE−/− Mice. Psychosomatic Medicine. 72(4). 376–382. 54 indexed citations
14.
Brooks, Larry & David Loewenstein. (2010). Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions. Alzheimer s Research & Therapy. 2(5). 28–28. 84 indexed citations
15.
Nation, Daniel A., Armando J. Mendez, Julia Zaias, et al.. (2008). The Effect of Social Environment on Markers of Vascular Oxidative Stress and Inflammation in the Watanabe Heritable Hyperlipidemic Rabbit. Psychosomatic Medicine. 70(3). 269–275. 31 indexed citations
16.
Szeto, Angela, Daniel A. Nation, Armando J. Mendez, et al.. (2008). Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. American Journal of Physiology-Endocrinology and Metabolism. 295(6). E1495–E1501. 170 indexed citations
17.
Baker, Dewleen G., et al.. (2003). The effects of homeopathic Argentum nitricum on test anxiety. Complementary Therapies in Medicine. 11(2). 65–71. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026